Package Leaflet: Information for the user
Dolomedil 500 mg/10 mg tablets
Paracetamol/codeine phosphate hemihydrate
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
Dolomedil contains paracetamol and codeine phosphate as active ingredients. Paracetamol belongs to a group of medicines called analgesics and antipyretics, and codeine is an opioid analgesic.
Dolomedil is indicated for the symptomatic treatment of moderate intensity acute pain in patients over 12 years old for whom the use of ibuprofen or paracetamol as a single analgesic is not considered appropriate.
Do not take Dolomedil
Warnings and precautions
It is essential to use the smallest dose that relieves pain and not to exceed the recommended doses in Section 3 – “How to take Dolomedil.” To do this, avoid taking other medications that contain paracetamol or codeine (used, for example, to treat colds, pain, and fever).
Consult your doctor, pharmacist, or nurse before starting to take Dolomedil:
If the pain persists for more than 3 days (2 days for throat pain), worsens, or other symptoms appear, you should interrupt treatment and consult your doctor.
During treatment with Dolomedil, immediately inform your doctor if:
You have severe diseases, such as severe renal insufficiency or sepsis (when bacteria and their toxins circulate in the blood, causing damage to organs), or if you suffer from malnutrition, chronic alcoholism, or if you are also taking flucloxacillin (an antibiotic). A severe disease called metabolic acidosis (a blood and fluid anomaly) has been reported in patients in these situations when paracetamol is used at regular doses for a prolonged period or when paracetamol is taken with flucloxacillin. The symptoms of metabolic acidosis may include: severe respiratory difficulty with deep and rapid breathing, drowsiness, feeling unwell (nausea), and vomiting.
Interference with analytical tests
If you are to undergo any analytical test (including blood, urine, skin tests using allergens, etc.) inform your doctor that you are taking this medication, as it may alter the results of these tests.
Use of Dolomedil with other medications
Inform your doctor or pharmacist if you are using or have recently used other medications, even those purchased without a prescription.
In particular, if you are using medications that contain any of the following active principles, it may be necessary to modify the dose or interrupt the treatment of any of them.
Paracetamol may interact with the following medications:
On the other hand, codeine may interact with the following medications:
Do not use with other analgesics (pain-relieving medications) without consulting your doctor.
The concomitant use of codeine and sedatives such as benzodiazepines or related medications increases the risk of drowsiness, breathing difficulties (respiratory depression), coma, and may be fatal. Therefore, concomitant use should only be considered when other treatment options are not possible.
However, if your doctor prescribes codeine along with sedatives, the dose and duration of concomitant treatment should be limited by your doctor.
Inform your doctor about all sedatives you are taking and follow your doctor's recommendations carefully regarding the dose. It may be helpful to inform friends or family members to be aware of the mentioned signs and symptoms. Contact your doctor when you experience these symptoms.
Taking Dolomedil with food, drinks, and alcohol
The use of paracetamol in patients who regularly consume alcohol (three or more alcoholic beverages per day) may damage the liver. Additionally, alcohol may potentiate the depressant effect of codeine. Therefore, do not consume alcohol during treatment with this medication.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, or if you think you may be pregnant or intend to become pregnant, consult your doctor or pharmacist before using this medication.
Do not take this medication during breastfeeding. Codeine and morphine pass into breast milk.
Driving and operating machines
Dolomedil contains codeine, which may cause drowsiness, altering mental and/or physical ability.
If you experience these effects, avoid driving vehicles or operating machines.
Dolomedil contains hydrogenated ricin oil
This medication may cause stomach discomfort and diarrhea due to the presence of hydrogenated ricin oil.
Use in athletes:This medication contains codeine. As a result of its metabolism, some compounds are produced that may produce a positive result in doping control tests.
Follow exactly the administration instructions for Dolomedil indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist.
This medication should not be taken for more than 3 days. If the pain does not subside in 3 days, you should consult your doctor.
The recommended dose is:
Adults:
1 or 2 tablets every 4 or 6 hours depending on the severity of symptoms, up to a maximum of 8 tablets per day. Intervals between doses should be at least 4 hours. It is recommended to start treatment with 2 tablets.
Use in children and adolescents
Adolescents 12 to 18 years old: 1 tablet 4 or 5 times a day, as needed, and up to a maximum of 5 tablets per day.
Do not use in patients under 12 years old due to the risk of severe respiratory problems.
Maximum recommended doses
In adults, the maximum dose corresponds to 8 tablets per day, and 5 tablets for adolescents 12 to 18 years old.
Patients with kidney and/or liver diseases
If you have a kidney and/or liver disease, your doctor may prescribe a lower dose than usual. If so, take the exact dose prescribed by your doctor.
Older patients
Older people are more prone to adverse effects, so it may be necessary to reduce the dose. Consult your doctor.
Instructions for correct administration of the preparation
Dolomedil is administered orally.
The tablets should be taken with a glass of liquid, preferably water or another non-alcoholic liquid.
If you take more Dolomedil than you should
If you have taken more Dolomedil than you should, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount used. It is recommended to bring the packaging and the medication leaflet to the healthcare professional.
The symptoms of overdose due to paracetamol may be: dizziness, vomiting, loss of appetite, yellowing of the skin and eyes (jaundice), and abdominal pain.
In cases where the patient is being treated with barbiturates or has chronic alcoholism, they may be more susceptible to a paracetamol overdose.
The symptoms that characterize a codeine overdose are: drowsiness, even to the point of stupor or coma, cold skin, miosis, muscle flaccidity, and, in some cases, bradycardia, hypotension, and respiratory depression.
If you forget to take Dolomedil
Do not take a double dose to compensate for the missed doses.
If you have forgotten a dose, take it as soon as possible and continue with the new schedule, maintaining the minimum interval between doses. However, if the next dose is due soon, skip the missed dose and take the next dose at its usual time.
If you interrupt the treatment with Dolomedil
Your doctor will indicate the duration of treatment with Dolomedil and when and how you should interrupt it. Do not suspend treatment prematurely, as you will not achieve the expected effect.
There is a risk of possible effects derived from abstinence when suspending treatment. Therefore, in prolonged treatments, doses should be gradually reduced (see section 2).
If you have any other doubts about the use of this medication, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
The observed side effects are described below according to the frequency of presentation:
Rare (may affect up to 1 in 1,000 patients) and very rare (may affect up to 1 in 10,000 patients).
The side effects ofparacetamolare:
Rare: Discomfort, increased levels of liver transaminases (liver enzymes) and hypotension (decreased blood pressure).
Very rare: Allergic reactions (hypersensitivity) ranging from a simple skin rash (redness or inflammation of the skin) or urticaria (hives) to anaphylactic shock (a type of severe allergic reaction), hepatotoxicity (liver toxicity), jaundice (yellow discoloration of the skin and mucous membranes), hypoglycemia (low blood glucose levels), thrombocytopenia (low platelet count), agranulocytosis, leukopenia, neutropenia (low white blood cell count), hemolytic anemia (low red blood cell count), sterile pyuria (cloudy urine), and adverse renal effects.
Very rarely, severe skin reactions have been reported.
Unknown frequency(cannot be estimated from available data): A serious disease that can make the blood more acidic (metabolic acidosis) in patients with severe disease who use paracetamol (see section 2).
The side effects ofcodeineare:
Rare: Discomfort, drowsiness (feeling of sleep), constipation, nausea, and dizziness, bronchospasm (bronchial spasms that make breathing difficult) and respiratory depression (slow breathing).
Very rare: Allergic reactions (hypersensitivity) ranging from a simple skin rash or urticaria to anaphylactic shock, fever, jaundice (yellow discoloration of the skin and eyes), hypoglycemia, thrombocytopenia, agranulocytosis, leukopenia, neutropenia, and hemolytic anemia.
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for human use: www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep out of sight and reach of children.
No special storage conditions are required.
Do not use this medication after the expiration date that appears on the packaging after “CAD”. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash. Dispose of packaging and unused medicines at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medicines. By doing so, you will help protect the environment.
Composition of Dolomedil
Appearance of the product and contents of the packaging
Dolomedil tablets are white, biconvex, oblong, and scored on both faces. The tablets are packaged in PVC/Alu blisters. Each package contains 20 tablets.
The score serves to break and facilitate swallowing but not to divide into equal doses.
Holder of the marketing authorization and responsible for manufacturing
Kern Pharma, S.L.
Venus, 72 – Pol. Ind. Colón II
08228 Terrassa - Barcelona
Spain
Last review date of this leaflet: January 2025
The detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.